Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun;5(6):1029-35.
doi: 10.2215/CJN.08181109. Epub 2010 Apr 8.

The longevity of arteriovenous graft for hemodialysis patients--externally supported or nonsupported

Yen-Ni Hung  1 , Po-Jen Ko, Yee-Yung Ng, Shiao-Chi Wu
Affiliations

The longevity of arteriovenous graft for hemodialysis patients--externally supported or nonsupported

Yen-Ni Hung et al. Clin J Am Soc Nephrol. 2010 Jun.

Abstract

Background and objectives: Because thrombosis and stenosis are the most frequent causes of arteriovenous graft (AVG) failure, several externally supported grafts were designed to enhance incompressibility and kinking resistance to improve the patency. However, consensus on advantage of these modifications having still not been reached might relate to the previous limited patient numbers and small studies. This study analyzed the longevity of externally supported and nonsupported AVG on the basis of the nationwide database to understand whether the externally supported design could improve the duration of patency of AVG.

Design, setting, participants, & measurements: Adult incident patients (n = 4402) were retrospectively enrolled who had began hemodialysis between January 1, 2002 and December 31, 2005. All incident patients with AVG, before or after beginning regular hemodialysis, between January 1, 2000 and December 31, 2006 were identified. The Cox proportional hazard model was used to compare the longevity of externally supported and nonsupported AVG by controlling other covariates.

Results: There were 990 patients with externally supported AVG and 3412 patients with nonsupported AVG. The patency rates of externally supported AVG were 49.4%, 31.6%, and 20.2% at 1, 2 and 3 years, respectively; those of nonsupported AVG were 31.9%, 17.4%, and 10.8%. The survival of nonsupported AVG was significantly inferior to that of externally supported AVG.

Conclusions: Externally supported AVG are superior to nonsupported AVG for long-term patency. The incompressibility and kinking resistance of ringed grafts may shed light on a direction for the future development of dialysis graft design.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Graphs of the covariate-adjusted estimated survivorship function by graft type. The survival of externally supported AVG was significantly better than that for the nonsupported AVG (P < 0.0001). Covariates include sex, age, time of vascular access creation, and congestive heart failure disease.
See this image and copyright information in PMC

References

    1. Megerman J, Levin NW, Ing TS, Dubrow AJ, Prosl FR: Development of a new approach to vascular access. Artif Organs 23: 10–14, 1999 - PubMed
    1. Arora P, Kausz AT, Obrador GT, Ruthazer R, Khan S, Jenuleson CS, Meyer KB, Pereira BJ: Hospital utilization among chronic dialysis patients. J Am Soc Nephrol 11: 740–746, 2000 - PubMed
    1. Besarab A, Detroit MI: Clinical practice guidelines for vascular access, update 2006. Am J Kidney Dis 48: S176–S247, 2006 - PubMed
    1. Ng YY, Wu SC, Hung YN, Ko PJ: Effect of demographic characteristics and timing of vascular access maturation on patency in Chinese incident hemodialysis patients. Nephrol Dial Transpl 24: 3447–3453, 2009 - PubMed
    1. Liu YH, Hung YN, Hsieh HC, Ko PJ: Surgical thrombectomy for thrombosed dialysis grafts: Comparison of adjunctive treatments. World J Surg 32: 241–245, 2008 - PubMed

Publication types

MeSH terms